NCT00601900-D2

Dataset Information

Dataset ID: NCT00601900-D2

PubMed ID (PMID):

Publication Title:

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor–Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)

Description of Dataset:

NCT00601900-D2 (AE) data set allows you to reproduce the reported adverse events for this study.

Data Dictionary:

NCT00601900-D2-Data-Dictionary.pdf

Submission includes new data:

Yes

Trials Linked to Dataset

NCT Trial Number	Disease Type
NCT00601900	Breast Neoplasm - Breast Cancer (Invasive)

Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security

U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov

NIH…Turning Discovery Into Health^®